TEARLAB
TearLab Corporation develops and markets lab-on-a-chip technologies that enable eye care practitioners to improve standard of care by objectively and quantitatively testing for disease markers in tears at the point-of-care. The TearLab Osmolarity Test, for diagnosing Dry Eye Disease, is the first assay developed for the award winning TearLab Osmolarity System. Headquartered in San Diego, CA, TearLab Corporation's common shares trade on the NASDAQ Capital Market under the symbol TEAR and on the Toronto Stock Exchange under the symbol TLB.
TEARLAB
Industry:
Hardware Health Care Medical Device
Founded:
2003-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.tearlab.com
Total Employee:
101+
Status:
Active
Contact:
(858)812-0540
Email Addresses:
[email protected]
Total Funding:
54.6 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Google Tag Manager Google Universal Analytics Domain Not Resolving Euro IPv6 Cloudflare Network Error Logging Facebook Pixel
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
CRG
CRG investment in Post-IPO Debt - TearLab
